The india diagnostics market size was valued at USD 2,013.5 million in 2021 and is poised to grow at a significant CAGR of 16.3% during the forecast period 2022-28. Increasing demand for novel healthcare facilities, rise in awareness of various diseases, health consciousness among people, growing per capita income, and high need for regular health check-ups in recent periods in India will be expected to drive the India diagnostics market over the forecast period. Rising awareness of communicable and non-communicable diseases among the population and subsequent preventive/treatment measures by regular monitoring of health with frequent check-ups under physician guidance is also a significant factor to drive the diagnostics market over the forecast period. The Indian diagnostics market players are majorly focusing on the majority of the in-vitro diagnostic products. However, while entering into new domains or developing a new product that has a more lucrative opportunity in the Indian IVD market, these companies follow a few strategic procedures. For instance, The Agappe company has focused on the hematology domain and started developing hematology analyzers. The company hired a clinical guide and a technical expert who has worked in several multinational corporations' research and development departments to develop this product. Finally, the company developed and launched India's first indigenous three-part diff hematology system.

View Detailed Report Description Here - https://precisionbusinessinsights.com/market-reports/india-diagnostics-market/  

Clinical Chemistry Segment Dominates the India Diagnostics Market
In 2021, the clinical chemistry segment accounted for a larger revenue share and projected to grow with a CAGR of 15.4% from 2022-2028, owing to the launch of newer diagnostics products. Government initiatives toward public health awareness programs, frequent rural camps for healthcare services, and free medical support for people who don’t have access to medical check-ups are also considerable factors driving the overall healthcare industry in India. Investments from private companies in healthcare industries and public and private companies’ projects to raise awareness of public health and wellness programs in recent periods in India are also a few significant factors expected to drive the India diagnostics market over the forecast period. Imports from other countries act as a growth restraint in the worldwide India diagnostics market. India diagnostics market is highly fragmented and unorganized due to the lack of regulations

India diagnostics market segmentation:

• By Segment Type: Immunodiagnostics, Clinical Chemistry, Tissue Diagnostics, Haematology, Point of Care Tests, Molecular Diagnostics, and Others
• By Product Type: Instruments/Analysers and Reagents and Kits
• By Application Areas: Infectious Disease, Oncology, Hormone, Diabetes, Cardiac, and Others
• By End User: Diagnostic Chains, Individual Diagnostic Laboratories, Hospital Laboratories, and Others

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=41411

Key player’s profiles in the India diagnostics market include Roche Diagnostics India Private Limited, Siemens Ltd. (Siemens Healthineers India), Becton Dickinson India Pvt Ltd, Beckman Coulter India Private Limited, Abbott India, Transasia Bio-Medicals Limited, Tulip Diagnostics Pvt Ltd, Trivitron Healthcare Pvt Ltd, Agappe Diagnostics Limited, Accurex Biomedical Pvt Ltd

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

The india diagnostics market size was valued at USD 2,013.5 million in 2021 and is poised to grow at a significant CAGR of 16.3% during the forecast period 2022-28. Increasing demand for novel healthcare facilities, rise in awareness of various diseases, health consciousness among people, growing per capita income, and high need for regular health check-ups in recent periods in India will be expected to drive the India diagnostics market over the forecast period. Rising awareness of communicable and non-communicable diseases among the population and subsequent preventive/treatment measures by regular monitoring of health with frequent check-ups under physician guidance is also a significant factor to drive the diagnostics market over the forecast period. The Indian diagnostics market players are majorly focusing on the majority of the in-vitro diagnostic products. However, while entering into new domains or developing a new product that has a more lucrative opportunity in the Indian IVD market, these companies follow a few strategic procedures. For instance, The Agappe company has focused on the hematology domain and started developing hematology analyzers. The company hired a clinical guide and a technical expert who has worked in several multinational corporations' research and development departments to develop this product. Finally, the company developed and launched India's first indigenous three-part diff hematology system.

View Detailed Report Description Here - https://precisionbusinessinsights.com/market-reports/india-diagnostics-market/  

Clinical Chemistry Segment Dominates the India Diagnostics Market
In 2021, the clinical chemistry segment accounted for a larger revenue share and projected to grow with a CAGR of 15.4% from 2022-2028, owing to the launch of newer diagnostics products. Government initiatives toward public health awareness programs, frequent rural camps for healthcare services, and free medical support for people who don’t have access to medical check-ups are also considerable factors driving the overall healthcare industry in India. Investments from private companies in healthcare industries and public and private companies’ projects to raise awareness of public health and wellness programs in recent periods in India are also a few significant factors expected to drive the India diagnostics market over the forecast period. Imports from other countries act as a growth restraint in the worldwide India diagnostics market. India diagnostics market is highly fragmented and unorganized due to the lack of regulations

India diagnostics market segmentation:

• By Segment Type: Immunodiagnostics, Clinical Chemistry, Tissue Diagnostics, Haematology, Point of Care Tests, Molecular Diagnostics, and Others
• By Product Type: Instruments/Analysers and Reagents and Kits
• By Application Areas: Infectious Disease, Oncology, Hormone, Diabetes, Cardiac, and Others
• By End User: Diagnostic Chains, Individual Diagnostic Laboratories, Hospital Laboratories, and Others

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=41411

Key player’s profiles in the India diagnostics market include Roche Diagnostics India Private Limited, Siemens Ltd. (Siemens Healthineers India), Becton Dickinson India Pvt Ltd, Beckman Coulter India Private Limited, Abbott India, Transasia Bio-Medicals Limited, Tulip Diagnostics Pvt Ltd, Trivitron Healthcare Pvt Ltd, Agappe Diagnostics Limited, Accurex Biomedical Pvt Ltd

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747